BMRN ▼ -1.1% - BioMarin Pharmaceutical Inc.
$BMRN BMRN - BioMarin Announces Five-Year Phase 3 Data for POMBILITI® (cipaglucosidase alfa-atga) + OPFOLDA® (miglustat) at World Muscle Society Annual Congress
02-OCT-2026 11:01 AM ET
Share this post
More filings for $BMRN
BMRN ▲ +0.5% - BioMarin Pharmaceutical Inc.Sep 14, 2026BMRN ▲ +0.2% - BioMarin Pharmaceutical Inc.Sep 9, 2026BMRN ▲ +0.0% - BioMarin Pharmaceutical Inc.Sep 1, 2026BMRN ▼ -0.9% - BioMarin Pharmaceutical Inc.Aug 31, 2026
View full $BMRN filing history →💬 Comments
Loading comments…
Leave a comment